What are the 10 drugs negotiated by Medicare for 2026?

Editorial team Published on

The first 10 prescription drugs with Medicare-negotiated maximum fair prices took effect on January 1, 2026, under the Medicare Drug Price Negotiation Program.

The 10 Negotiated Drugs

  • Eliquis (apixaban) – Blood clots
  • Enbrel (etanercept) – Rheumatoid arthritis and psoriasis
  • Entresto (sacubitril/valsartan) – Heart failure
  • Farxiga (dapagliflozin) – Diabetes and heart failure
  • Fiasp / NovoLog (insulin aspart products) – Diabetes
  • Imbruvica (ibrutinib) – Blood cancers
  • Januvia (sitagliptin) – Diabetes
  • Jardiance (empagliflozin) – Diabetes
  • Stelara (ustekinumab) – Psoriasis and Crohn's disease
  • Xarelto (rivaroxaban) – Blood clots

What are the medications on the Medicare drug list for 2026?

Medicare does not have a single, universal drug list; instead, each private insurance company running a Medicare Part D or Medicare Advantage plan creates its own approved list of covered medications called a formulary.

Common Medications Covered in 2026

While lists vary by plan, nationwide Part D and Medicare Advantage formularies (such as those from UnitedHealthcare and Humana) typically include thousands of standard generic and brand-name drugs, including:

  • Cholesterol and Blood Pressure: Atorvastatin, Lisinopril, Rosuvastatin, Metoprolol, Furosemide, Valsartan
  • Diabetes Management: Metformin, Januvia, Pioglitazone, and various insulins (capped at $35 per month)
  • Mental Health and Neurology: Aripiprazole, Duloxetine, Escitalopram, Memantine, Quetiapine
  • Gastrointestinal: Omeprazole, Pantoprazole, Esomeprazole, Lansoprazole
  • Common Brands: Advair Diskus, Spiriva, Crestor, Lipitor, Lexapro

How Coverage and Tiers Work

  • Drug Tiers: Plans group drugs into tiers—ranging from Preferred Generics (Tier 1) to Specialty Drugs (Tier 5)—which determine your copay or coinsurance costs.
  • Coverage Rules: Many medications require Prior Authorization (PA), Quantity Limits (QL), or Step Therapy (ST) before the plan will pay for them.
  • Finding Your Specific List: You can look up coverage specifics using the 2026 Medicare Part D Plan Finder or by checking the exact formulary provided by your specific insurance provider.

What are the 10 medications being negotiated?

The first 10 prescription medications selected by Medicare for price negotiations under the Inflation Reduction Act—with negotiated prices taking effect in 2026—are listed below:

The First 10 Negotiated Medications

  • Eliquis (apixaban) – Used for blood clot prevention and treatment.
  • Jardiance (empagliflozin) – Used for type 2 diabetes, heart failure, and chronic kidney disease.
  • Xarelto (rivaroxaban) – Used for blood clot prevention and treatment.
  • Januvia (sitagliptin) – Used for type 2 diabetes.
  • Farxiga (dapagliflozin) – Used for type 2 diabetes, heart failure, and chronic kidney disease.
  • Entresto (sacubitril/valsartan) – Used for heart failure.
  • Enbrel (etanercept) – Used for rheumatoid arthritis, psoriasis, and psoriatic arthritis.
  • Imbruvica (ibrutinib) – Used for blood cancers.
  • Stelara (ustekinumab) – Used for psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
  • NovoLog / Fiasp (insulin aspart formulations) – Used for diabetes.

What are the 10 most expensive Medicare drugs?

The 10 costliest prescription drugs for Medicare—based on total overall program spending and targeted under the initial federal price negotiation program—include widely used treatments for blood clots, diabetes, and cancer.

Top 10 High-Spend Medicare Part D Drugs

The first 10 medications selected for maximum price adjustments under the Centers for Medicare & Medicaid Services framework represent some of the highest total expenditures for the program:

  • Eliquis (apixaban): Anticoagulant used to prevent and treat blood clots.
  • Jardiance (empagliflozin): Treats type 2 diabetes and heart failure.
  • Xarelto (rivaroxaban): Blood thinner used for stroke and blood clot prevention.
  • Farxiga (dapagliflozin): Manages type 2 diabetes, heart failure, and chronic kidney disease.
  • Januvia (sitagliptin): Oral medication to control blood sugar in type 2 diabetes.
  • Entresto (sacubitril/valsartan): Combination drug prescribed for heart failure.
  • Stelara (ustekinumab): Biologic therapy for Crohn’s disease, psoriasis, and plaque psoriasis.
  • Enbrel (etanercept): Treats rheumatoid arthritis and other autoimmune conditions.
  • NovoLog / Fiasp (insulin aspart): Rapid-acting insulins for blood glucose control.
  • Imbruvica (ibrutinib): Targeted cancer therapy for specific blood cancers like leukemias.

How much will Jardiance cost with Medicare in 2026?

In 2026, the maximum amount your Medicare Part D plan can pay for a 30-day supply of Jardiance is capped at a negotiated price of $197. However, your actual out-of-pocket cost will likely be much lower, averaging around $43 per month, depending on your specific plan's structure and what phase of coverage you are in.

The cost of Jardiance dropped significantly starting January 1, 2026, because it was selected as one of the first 10 medications subject to the federal government's historic Medicare drug price negotiation program. Its total base cost dropped roughly 66%, from a previous list price of $573 down to $197.

How Your Cost Breakdown Works

Your exact payment at the pharmacy depends on the standard phases of Medicare Part D coverage:

  • Deductible Phase: If you haven’t met your plan's annual deductible (which can be a maximum of $615 in 2026), you will pay the full negotiated price of $197 until the deductible is satisfied.
  • Initial Coverage Phase: Once your deductible is met, your cost drops significantly. For most plans where Jardiance sits on a preferred tier, you will pay a flat copay or a percentage (coinsurance). This averages $0 to $50 per month for the majority of enrollees.
  • Extra Help: If you qualify for the federal Medicare Extra Help Program, your monthly out-of-pocket cost for Jardiance drops even further, capped roughly between $5.10 and $12.65.

The 2026 Medicare Out-of-Pocket Safety Net

Regardless of how many expensive medications you take, you are protected by a federal mandate. For 2026, Medicare Part D features a $2,100 maximum annual out-of-pocket cap on all covered prescription drugs. Once your combined deductibles, copays, and coinsurance hit $2,100 for the year, your plan covers 100% of your remaining prescription costs, meaning Jardiance will cost you $0 for the rest of that calendar year.

Note: To see exactly how your specific insurer classifies this medication, log into your account on the official Medicare Plan Finder or check your plan's 2026 formulary ("Summary of Benefits") document.

10 Negotiated drugs for Medicare for 2026!

9 related questions found

Which Medicare drugs will be affected by negotiated drug prices in 2026?

The first 10 Medicare Part D brand-name drugs with negotiated Maximum Fair Prices officially went into effect on January 1, 2026.

💊 The 10 Negotiated Drugs for 2026

  • Eliquis (blood thinner)
  • Jardiance (diabetes/heart failure)
  • Xarelto (blood thinner)
  • Januvia (diabetes)
  • Entresto (heart failure)
  • Stelara (psun/Crohn's)
  • Imbruvica (blood cancer)
  • NovoLog / Fiasp (insulin products)
  • Farxiga (diabetes/kidney/heart)
  • Enbrel (rheumatoid arthritis)

📊 Price Reductions & Savings

  • Discounts: Ranging from 38% to 79% off 2023 list prices.
  • Highest cut: Januvia (79% off).
  • Lowest cut: Imbruvica (38% off).

⚠️ What to Know at the Pharmacy

  • Not a flat copay drop: Your actual out-of-pocket cost depends on your specific Part D plan’s deductible and tier structure.
  • Cap on costs: Total out-of-pocket prescription spending for Part D enrollees is capped at $2,100 in 2026.
  • Future rounds: Additional drugs selected in later cycles take effect in 2027 and 2028.

What is the best drug plan for seniors on Medicare?

The best Medicare prescription drug plan depends on the specific medications you take and your local ZIP code, though national providers like Wellcare and Humana top industry ratings for affordability and value.

Top-Rated National Providers

  • Wellcare: Recognized for low monthly premiums, with some stand-alone Part D plans starting at $0 per month.
  • Humana: Highly rated for low out-of-pocket costs and strong benefits for managing chronic conditions like diabetes.
  • UnitedHealthcare (AARP): Noted for high customer satisfaction and extensive nationwide availability.

Key Details to Consider

  • The $2,100 Out-of-Pocket Cap: All Medicare Part D plans feature a yearly maximum out-of-pocket spending limit of $2,100 for covered drugs, after which your medications are free for the rest of the year.
  • Insulin Savings: Out-of-pocket costs for covered insulin are capped at $35 per month under Medicare Part D.
  • Formulary Match: A plan is only "best" if it covers the specific brand-name or generic drugs you currently take.

How to Find Your Best Plan

To see exact pricing and coverage for your prescriptions, use the official Medicare Plan Finder Tool to compare local options.

What 5 medications do doctors say not to take?

Doctors often recommend getting rid of or avoiding specific over-the-counter and routine medications because new evidence shows they are ineffective or carry unnecessary risks.

Based on recent medical guidance highlighted by physicians (such as recent recommendations featured by the Washington Post), here are 5 medications doctors frequently advise reconsidering or dropping from your medicine cabinet:

1. Oral Phenylephrine

  • What it is: A common oral decongestant found in many over-the-counter cold, flu, and sinus products (like certain versions of Sudafed PE or DayQuil).
  • Why doctors say to avoid it: The FDA determined that oral phenylephrine is completely ineffective as a nasal decongestant.
  • What to do instead: If you need a real oral decongestant, ask a pharmacist for pseudoephedrine from behind the pharmacy counter, which actually works.

2. Diphenhydramine (Benadryl)

  • What it is: A first-generation antihistamine widely used for allergies and sleep.
  • Why doctors say to avoid it: Especially for adults over 65, it causes severe side effects like heavy daytime grogginess, confusion, high risk of falls, and trouble urinating. Chronic use has also been linked to cognitive decline.
  • What to do instead: Switch to newer, safer second-generation antihistamines like loratadine (Claritin) or cetirizine (Zyrtec).

3. Daily Low-Dose Aspirin (for Primary Prevention)

  • What it is: Taking a daily aspirin to prevent a first heart attack or stroke.
  • Why doctors say to avoid it: Updated guidelines advise against starting daily aspirin if you have never had a cardiovascular event, because the risk of dangerous stomach bleeding often outweighs the preventative benefits. (Note: If you already take it under strict doctor's orders for an existing heart condition, do not stop without talking to them).
  • What to do instead: Talk to your physician to re-evaluate your personal risk factors and see if a daily aspirin is still appropriate for you.

4. Docusate Sodium (Colace)

  • What it is: A widely sold over-the-counter stool softener.
  • Why doctors say to avoid it: Robust clinical trials have shown it is largely ineffective as a standalone treatment for constipation.
  • What to do instead: Increase your intake of water and try a natural fiber supplement or osmotic laxative if recommended by your care team.

5. Old Codeine Cough Syrup

  • What it is: Prescription opioid-based cough medicine kept in home medicine cabinets.
  • Why doctors say to avoid it: Studies show codeine cough syrup performs no better than a placebo for suppressing coughs, but carries serious risks of dependence, accidental misuse, and dangerous slowed breathing.
  • What to do instead: Safely dispose of leftover prescription narcotics through a community drug take-back program.

What is the most expensive prescription drug in the US?

The most expensive prescription drug in the United States is Lenmeldy, which has a list price of $4.25 million for a one-time treatment.

Why It Costs So Much

  • Condition: It treats metachromatic leukodystrophy (MLD), a rare and fatal genetic nervous system disease in children.
  • Type of Drug: It is a single-administration gene therapy. Gene therapy replaces or fixes faulty genes to offer a cure rather than managing symptoms over a lifetime.
  • Manufacturing: Making these advanced biological treatments requires complex, high-tech laboratory processes for very small groups of patients.

Other Extremely Expensive US Drugs

Other top-tier, ultra-high-cost gene therapies and specialty medications include:

  • Hemgenix: $3.5 million (one-time treatment for hemophilia B)
  • Elevidys: $3.2 million (one-time treatment for Duchenne muscular dystrophy)
  • Lyfgenia: $3.1 million (one-time treatment for sickle cell disease)
  • Zolgensma: $2.32 million (one-time treatment for spinal muscular atrophy)

Is GoodRx better than Medicare Part D?

GoodRx is not "better" than Medicare Part D overall because GoodRx is a discount coupon program, not insurance.

Key Differences

  • Medicare Part D is health insurance. It protects you against catastrophic costs, covers expensive brand-name and specialty medications, and includes an annual out-of-pocket spending cap ($2,100).
  • GoodRx is a free price-comparison and coupon tool. It does not replace insurance and does not count toward your Medicare deductible or out-of-pocket maximum.

When GoodRx is Better

  • Cheap Generic Drugs: GoodRx often beats insurance copays for low-cost generic medications.
  • Uncovered Drugs: If a prescribed medication is not on your Part D plan's formulary (list of covered drugs), GoodRx can lower the cash price.
  • Before Meeting Deductibles: If your Part D plan has a deductible and the cash price with GoodRx is lower than what you would pay out of pocket initially.

When Medicare Part D is Better

  • Brand-Name and Specialty Drugs: GoodRx offers very little savings on expensive brand-name drugs, which can cost thousands of dollars a month and easily bankrupt a cash-pay patient.
  • Safety Net: Part D caps your annual out-of-pocket spending, whereas GoodRx offers no yearly cap or protection if you develop a severe, expensive health condition. Dropping Part D entirely also risks permanent late-enrollment penalties.

You cannot combine GoodRx and Medicare Part D at the register; you must choose to run a prescription through either your insurance or as a cash transaction using GoodRx. Many beneficiaries keep a Part D plan for major protection while spot-checking GoodRx for cheaper generic fills.